PURE Bioscience Hosts Year-End Results Conference Call October 28, 2014 to Review Progress of SDC Antimicrobial-Based Food Safety Solutions Strategy
(firmenpresse) - SAN DIEGO, CA -- (Marketwired) -- 10/20/14 -- (OTCQB: PURE), creator of the patented silver dihydrogen citrate () antimicrobial, today announced that the Company will host an investor conference call on Tuesday, October 28, 2014 at 1:30pm PDT (4:30pm EDT).
In addition to discussion of fiscal year end 2014 results, the will review the latest progress made in commercializing SDC as a food safety solution:
Quick Service Restaurants (QSRs) Status
Completed 650 store SUBWAY® Restaurants market test during fiscal Q4 2014.
Initiation of a phased system-wide sales rollout with SUBWAY® in the US.
FDA/USDA Applications for Direct Food Contact Status
Review process of SDC as a processing aid
For reduction of Salmonella in poultry
For reduction of Salmonella, E.coli and Listeria in produce
Initial SDC testing status for reduction of Salmonella and E.coli in beef and pork
The Participant Dial-In Number for the conference call is 1-631-982-4565. Participants should dial in to the call at least five minutes before 1:30pm PDT (4:30pm EDT) on October 28th, 2014. The call can also be accessed "live" online at .
A replay of the webcast will be available on the Company''s website (). Also, a replay of the conference call will be available by dialing 1-877-870-5176 (international participants dial 1-858-384-5517) starting October 28th, 2014, at 7:30pm Eastern Time through November 11th, 2014 at 11:59 pm Eastern Time. Please use PIN Number 90611.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the Company''s cash position and liquidity requirement;, the Company''s failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company''s current and future products and services in the marketplace, including acceptance of the Company''s Hard Surface disinfectant by SUBWAY franchisees; the ability of the Company to develop effective new products and receive regulatory approvals of such products; competitive factors; dependence upon third-party vendors, and other risks detailed in the Company''s periodic report filings with the Securities and Exchange Commission; including our quarterly report on Form 10-Q filed on June 10, 2014. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
Tom Hemingway
Redwood Investment Group
714-978-4425
Terri MacInnis, Director of IR
Bibicoff + MacInnis, Inc.
818-379-8500
Peter C. Wulff
CFO & COO
PURE Bioscience, Inc.
619-596-8600 ext.111
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 20.10.2014 - 06:36 Uhr
Sprache: Deutsch
News-ID 1311066
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SAN DIEGO, CA
Phone:
Kategorie:
Wholesalers and Distributers
Anmerkungen:
Diese Pressemitteilung wurde bisher 214 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"PURE Bioscience Hosts Year-End Results Conference Call October 28, 2014 to Review Progress of SDC Antimicrobial-Based Food Safety Solutions Strategy
"
steht unter der journalistisch-redaktionellen Verantwortung von
PURE Bioscience, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
